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A B S T R A C T
Background: Amphipathic cationic antimicrobial peptides (AMPs) TC19 and TC84, derived from the major AMPs
of human blood platelets, thrombocidins, and Bactericidal Peptide 2 (BP2), a synthetic designer peptide showed
to perturb the membrane of Bacillus subtilis. We aimed to determine the means by which the three AMPs cause
membrane perturbation in vivo using B. subtilis and to evaluate whether the membrane alterations are dependent
on the phospholipid composition of the membrane.
Methods: Physiological analysis was employed using Alexa Fluor 488 labelled TC84, various ﬂuorescence dyes,
ﬂuorescent microscopy techniques and structured illumination microscopy.
Results: TC19, TC84 and BP2 created extensive ﬂuidity domains in the membrane that are permeable, thus
facilitating the entering of the peptides and the leakage of the cytosol. The direct interaction of the peptides with
the bilayer create the ﬂuid domains. The changes caused in the packing of the phospholipids lead to the delo-
calization of membrane bound proteins, thus contributing to the cell's destruction. The changes made to the
membrane appeared to be not dependent on the composition of the phospholipid bilayer.
Conclusions: The distortion caused to the ﬂuidity of the membrane by the AMPs is suﬃcient to facilitate the
entering of the peptides and leakage of the cytosol.
General signiﬁcance: Here we show in vivo that cationic AMPs cause “membrane leaks” at the site of membrane
insertion by altering the organization and ﬂuidity of the membrane. Our ﬁndings thus contribute to the un-
derstanding of the membrane perturbation characteristic of cationic AMPs.
1. Introduction
With the rise of antibiotic resistance, antimicrobial peptides (AMPs)
have been proposed as an alternative novel class of antibiotics. Studies
seek to understand the mechanism of binding and membrane distortion
of AMPs with the intention to improve the design of synthetic or de-
rived peptides. Biophysical studies using model membrane systems are
commonly used since biological membranes tend to be multifarious,
whereas model membranes can have speciﬁcally deﬁned properties.
However, it is often in dispute about whether these studies fully explain
the complex interaction between AMPs and microbial membranes of
living cells. Knowledge of the mode of action of AMPs performed with
living microbial cells, to corroborate or to contradict observation made
with lipid vesicles, could be beneﬁcial in understanding the membrane
perturbation mechanism of AMPs.
“Pore-formation” of cationic peptides is associated with the toroidal
model, where the AMP is thought to insert into the membrane causing
the membrane to bend inward with the AMP-lipid head groups facing
the central pore [1]. The alternative model is the carpet model, where
the peptide accumulates at higher concentrations at the cell membrane
surface causing the membrane to break oﬀ into micelles structures as if
treated with a detergent [1,2]. Membrane thinning [3] and phase
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boundary defects [4–7] have also been associated with pore-formation.
However, instead of viewing pore-formation as a ordered event, it likely
should be considered stochastic as proposed in studies performed with
alamethicin [8], melittin [9], magainin [10] and maculatin [11]. Re-
cently, the mode of action of lipopeptide daptomycin and the non-pore-
forming cyclic hexapeptide cWFW [12,13] was attributed to the al-
tering of membrane ﬂuidity. Here we aimed at extending the analyses
on membrane ﬂuidity to our cationic AMPs derived from thrombocidin
(TC19 and TC84) and the designer peptide (BP2) that have been shown
to perturb the membrane of B. subtilis (Omardien, submitted). We ex-
pected to see similarities between the TC peptides, and possible dif-
ferences with BP2. BP2 was characterized previously by a very rapid
killing eﬃcacy and hence in that regard a bench-mark for the TC
peptides [14].
We found that TC19, TC84 and BP2 altered the ﬂuidity of the
membrane of B. subtilis vegetative cells. A-typical ﬂuid domains were
created within an otherwise rigid membrane. We propose that the
distortion of the membrane ﬂuidity leads to “pore-formation”, which
facilitate the passage of the peptides to the intracellular compartment.
Additionally, we found that the activity of TC19, TC84 and BP2 was not
necessarily dependent on the composition of the phospholipid bilayer
but on the presence of anionic phospholipids, as assessed using phos-
pholipid synthesis mutant B. subtilis strains.
2. Materials and methods
2.1. AMP information, strains used and the culturing conditions
Stocks of 1.2mM TC19 (LRCMCIKWWSGKHPK), TC84 (LRAMCIK-
WWSGKHPK) and BP2 (GKWKLFKKAFKKFLKILAC) were made in
0.01% acetic acid. Stocks were stored at −20 °C and thawed on ice
prior to each experiment. B. subtilis pre-cultures were prepared by in-
oculating a single colony from Luria Broth (LB) solid medium into 5ml
LB liquid medium and culturing overnight. The overnight culture was
re-inoculated to have an initial optical density at an absorbance of
600 nm (OD600) of 0.05 in complete minimal medium (CMM) or Luria
Broth (LB). CMM consist of Spizizen's Minimal Medium (SMM), as de-
scribed in Anagnostopoulos & Spizizen (1960) [15], with the mod-
iﬁcations described in Halbedel et al. (2014) [16]. The culture was
incubated until an OD600 of 0.4 to 0.6 (the early exponential growth
phase) was reached. Cultures were subsequently diluted for each ex-
periment to an optical density (OD600) of 0.2, if not speciﬁed otherwise.
Culturing was performed at 37 °C under continuous agitation at
200 rpm where appropriate. Culturing media were supplemented when
required as indicated at the speciﬁc experiment descriptions. Informa-
tion about Bacillus subtilis strains used in the study and the medium
supplements required for each strain can be found in the Table S1. The
Staphylococcus aureus strain NCTC8325 used in this study was pre-cul-
tured in LB but cultured in CMM.
2.2. Measuring loss of membrane potential using the ﬂuorescent probe
DiSC3(5)
To determine the loss of membrane potential after treatment with
the AMPs the ﬂuorescent dye 3,3′-dipropylthiadicarbocyanine iodide
(DiSC3(5)) was used. The method was followed as described in
Breeuwer & Abee [17] with some alterations. In brief, 200 μl diluted
pre-cultures of B. subtilis were added to each well in a 96-well ﬂat-
bottomed microtiter plate (μClear, polystyrene, black wall, clear
bottom, Greiner Bio-One). DiSC3(5) was added to each well to have a
ﬁnal concentration of 1.5 μM. Cells with an active membrane potential
will accumulate the dye in their membrane, reducing the DiSC3(5)
signal. Once the DiSC3(5) signal had reduced to close to zero, the AMPs
were added. Loss of membrane potential will cause release of the dye
again. As positive controls for membrane potential loss, valinomycin
(Sigma-Aldrich) was added at a ﬁnal concentration of 30 μM, and Nisin
A (> 95% purity; Handary, Belgium) at a ﬁnal concentration of 4 μM.
To a sample of untreated cells 1% DMSO was added to assess the total
ﬂuorescence of the dye taken up prior to initiation of treatment. Fol-
lowing treatment of the cells with the AMPs, additional valinomycin
was added at a ﬁnal concentration of 30 μM to dissipate the residual
membrane potential. The assay was performed at 37 °C while shaking.
Fluorescence was measured at an excitation wavelength of 622 nm and
emission wavelength of 670 nm, with the BioTek Synergy Mx, Gen5 2.0
(Winooski, VT) plate reader. Three biological repeats were performed.
2.3. Labelling procedure of peptide TC84 using Alexa Fluor 488
For solid phase peptide synthesis, the chemical procedures were
followed as described by Heimstra et al. [18]. The amino acid sequence
of TC84 was N-terminally elongated with a cysteine residue to enable
coupling of the Alexa Fluor 488. The internal cysteine residue was
protected during synthesis with an acid-stable StBu group, resulting in
the intermediate peptide C- L- R- A- M- C(StBu)- I- K- W- W- S- G- K- H-
P- K-amide. The intermediate peptide (18mg in 1ml DMSO) was added
to Alexaﬂuor488 C-5 maleimide (20mg in 1ml DMSO, A10254, Life
Technologies). To this solution 1 μl 4-methylmorpholine (NMM) was
added. The resulting mixture was vortexed for 10 s and left at room
temperature for 40min. The reaction was stopped by the addition of
500 μl acetic acid/water at a 9:1 ratio. The labelled product was pur-
iﬁed by reversed phase chromatography on a C18-column using water
to acetonitrile gradient containing 0.1% TFA, and lyophilized. The StBu
protected labelled peptide obtained was dissolved in 300 μl water/
acetonitrile at a 1:1 ratio and treated with ten-fold excess TCEP
(TCEP·HCl was neutralised with 4 N NaOH) for 3 h at room temperature
to remove the StBu protection. After lyophilisation and desalting on a
PD-10 column using water/acetonitrile/acid at a 40:60:10 ratio as an
eluent, the ﬁnal product was obtained (Microﬂex, Bruker). Quantiﬁ-
cation was performed by OD495 using an ε of 71,000. The labelled
peptide was stored at −20 °C until further use.
2.4. Laurdan staining to observe changes in membrane ﬂuidity after the
addition of peptides
Changes in membrane ﬂuidity were observed using Laurdan (6-
Dodecanoyl-N, N-dimethyl-2-naphthylamine; Sigma Aldrich), a ﬂuor-
escent probe sensitive to membrane phase transitions. For Laurdan
staining of B. subtilis cells, the method described by H. Strahl et al. [19]
was followed with minor alterations. The culture was incubated until an
OD600 of 0.4 to 0.6 was reached in CMM or LB. Laurdan, dissolved in
dimethylformamide (DMF), was added at a ﬁnal concentration of
10 μM. The mixture was incubated for an additional 5min at 37 °C
while shaking in the dark. Stained cells were washed (four times for
spectroscopy measurements and twice for microscopy) and re-sus-
pended in PBS buﬀer (PBS containing 0.2% w/v glucose and 1% v/v
DMF). The stained cells were diluted to an OD600 of 0.2 before the
addition of AMPs. Laurdan stained cells were washed only once after
staining for treatment with Alexa 488-labelled TC84. After Alexa 488-
labelled TC84 treatment, cells were subsequently washed four times
and re-suspended with pre-warmed PBS buﬀer.
Laurdan ﬂuorescence spectroscopy measurements were performed
by adding to each well of a 96-well ﬂat-bottomed microtiter plate
(μClear, polystyrene, black wall, clear bottom, Greiner Bio-One) stained
cells with AMPs to have a ﬁnal volume of 200 μl. Fluorescence was
measured in a BioTek Synergy Mx, Gen5 2.0 (Winooski, VT) plate
reader every 2min while shaking at 37 °C. After 4min of measuring,
AMPs were added and additional measurements were taken for 30min.
Laurdan was measured at an excitation wavelength of 350 nm and the
emission wavelength at 460 ± 5 nm ((liquid ordered or gel-phase; g)
and 500 ± 5 nm ((liquid disordered or liquid-phase; l). Laurdan gen-
eralized polarization (GP) was calculated using the formula Laurdan
GP= (Ig− Il) / (Ig+ Il), where Ig is the ﬂuorescent measurement in the
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gel-phase and Il the ﬂuorescent measurement in the liquid-phase. The
culture was maintained at 37 °C throughout the assay.
Laurdan microscopy measurements were performed by treating
stained cells for 5min with the AMPs before visualizing the Laurdan
using a temperature-controlled Nikon Eclipse Ti ﬂuorescence micro-
scope. Laurdan was excited at a wavelength of 340–380 nm and emis-
sion were at 435–485 nm (gel-phase) and 510–560 nm (liquid-phase).
Laurdan GP of the microscopy images were performed using the
CalculateGP ImageJ plugin designed by Norbert Vischer (https://sils.
fnwi.uva.nl/bcb/objectj/examples/CalculateGP/MD/gp.html).
2.5. DiIC12 staining to conﬁrm ﬂuid regions in membrane after peptide
treatment
DiIC12 is a short chain cationic lipophilic ﬂuorescent probe that
preferentially partitions into areas in the bilayer that is in ﬂuid-phase
(liquid disordered phase) [20]. Cells were stained before treatment by
culturing B. subtilis or S. aureus in CMM or LB containing 1 μg/ml DiIC12
(dissolved in DMSO) until an OD600 of 0.2 to 0.6 was reached. Stained
cells were diluted to an OD600 of 0.2 if necessary with CMM or LB
containing 1% v/v DMSO. Stained cells were washed four times with
medium and subsequently treated with AMPs for 5min. The culture was
maintained at 37 °C throughout the assay. Cells were visualized with a
Cy3 ﬁlter using a temperature-controlled Nikon Eclipse Ti ﬂuorescence
microscope.
2.6. Structure illumination microscopy (SIM) imaging of membrane after
peptide treatments
The B. subtilis PrpsD-sfGFP mutant constitutively produces the green
ﬂuorescent protein under control of the promotor for ribosomal protein
S4 and was used to observe membrane perturbation and cytosol
leakage. Diluted pre-cultures of B. subtilis PrpsD-sfGFP were treated
with the AMPs for 5min. AMP-treated cells were stained with Nile Red
(0.5 μg/ml ﬁnal concentration). The culture was maintained at 37 °C
throughout the assay. The Nikon N-SIM E microscope was used to vi-
sualize the cells. The coverslips were coated with L-dopamine to reduce
the binding of Nile Red in order to avoid distortion of the structured
illumination pattern projections [21,22].
2.7. Determining the binding site of peptide TC84 using Alexa-488 labelled
TC84
Pre-cultures of B. subtilis were washed once and re-suspended in
phosphate buﬀer saline (PBS, pH 7.4) containing 0.2% w/v glucose.
The suspensions were diluted to an OD600 of 0.2 with PBS with 0.2% w/
v glucose prior to treatment with 14 μM Alexa 488-labelled TC84.
Combination treatments of Alexa 488-labelled TC84 and active TC84 at
a 1:1 w/w mixture, to have a ﬁnal concentration of 14 μM were also
performed. Treatments were for 5min followed by two washing steps
with PBS with 0.2% w/v glucose to remove residual labelled peptide.
To determine whether the Alexa 488-labelled TC84 delocalize mem-
brane bound proteins, B. subtilis mutants producing the peripheral
membrane bound protein MreB (MreB-mCherry) and integral mem-
brane bound protein PBP2b (PBP2b-mCherry) fused to the ﬂuorescent
protein, mCherry, were used. Treatment of the B. subtilis mutants were
similar as mentioned above. The culture was maintained at 37 °C
throughout the assay. Fluorescence microscopy imaging with the Nikon
Elipse Ti was performed at an excitation wavelength and emission
wavelength for mCherry (570 ± 10 nm/620 ± 10 nm) and Alexa 488-
labelled TC84 (490 nm ± 5 nm/525 nm ± 5 nm). Labelling of TC84
with Alexa Fluor 488 reduced the eﬃcacy of the peptide up to 56 μM,
the highest concentration tested.
2.8. Killing eﬃcacy of peptides using mutants with an altered membrane
phospholipid composition
B. subtilis mutants were cultured in CMM containing the necessary
supplements for each strain (Table S1). In short, B. subtilis strain
MHB001 (pgsA) was cultured with erythromycin and isopropyl β-D-1-
thiogalactopyranoside (IPTG) at a ﬁnal concentration of 1mM or
0.1 mM to induce pgsA expression. B. subtilis strain HB5337 (mprF) was
cultured with kanamycin, HB5362 (ywnE) with chloramphenicol and
strain SDB206 (CL) with spectinomycin. Diluted pre-cultures were
treated with the AMPs for 30min. Aliquots were taken and diluted as
mentioned in the time-kill assay. The culture was maintained at 37 °C
throughout the assay. Results were expressed as numbers of CFU/ml.
Four biological repeats were performed. Statistical analysis was per-
formed in SigmaPlot 13.0.
2.9. Software and ﬂuorescence microscopes employed in the study
Microscopy images were analysed in ImageJ/Fiji (http://rbsweb.
nih.gov/ij/). Microscopy imaging was performed using the Nikon
Eclipse Ti equipped with an Intensilight HG 130W lamp, a C11440-
22CU Hamamatsu ORCA camera, a CFI Plan Apochromat DM 100× oil
objective and OkoLab stage incubator (Napoli, Italy). Structured illu-
mination microscopy (SIM) was performed with a Nikon Ti N-SIM
equipped with a CFI SR Apochromat TIRF 100× oil objective (NA1.49),
a LU-N3-SIM laser unit, an Orca-Flash 4.0 sCMOS camera (Hamamatsu
Photonics K·K). Software used for the Nikon Elipse Ti was the NIS ele-
ments software version 4.20.01 and for the SIM reconstruction was NIS-
elements Ar software.
3. Results
3.1. TC19, TC84 and BP2 dissipate the membrane potential gradually
Previously, it was observed that TC-1, the original protein design
template for TC19 and TC84, did not dissipate the membrane potential
of Lactococcus lactis [23]. Recently, lipopeptide daptomycin was shown
to cause a gradual membrane dissipation proﬁle compared to the K+/
Na+ channel-forming Gramicidin ABCD peptide mix, as detected using
the ﬂuorescent dye DiSC3(5) [12]. We employed DiSC3(5) to evaluate
whether TC19, TC84 and BP2 dissipate the membrane potential rapidly
as expected with pore-forming peptides. The positively charged
DiSC3(5) accumulates intracellularly during hyperpolarization of the
membrane and is released from the cell when depolarization takes place
[24]. A loss of DiSC3(5) signal is observed after the addition of the dye
due to its spectral shift once it is aggregated intracellularly. When the
ionophore valinomycin is added, it dissipates the membrane potential
in the presence of potassium ions, resulting in a rapid increase in the
DiSC3(5) signal [25]. The lantibiotic Nisin A was added as a control.
Nisin binds to lipid II, a membrane-anchored cell wall precursor that is
essential for cell wall biosynthesis, to form deﬁned pores [26].
Valinomycin instantly dissipated the membrane potential (Fig. 1).
Peptide TC84, TC19 and BP2 dissipated the membrane potential
(Fig. 1), but with lethal concentration of TC19 (14 μM), TC84 (14 μM)
and BP2 (3.5 μM) (Omardien, submitted) only a gradual increase in
DiSC3(5) signal was observed. A “lag time” of about 5min was required
before an increase in DiSC3(5) could be observed. Only after about
25min of treatment with TC19 and TC84 did the DiSC3(5) signal reach
its maximum, suggesting a slow depolarization of the membrane. The
delayed increase in DiSC3(5) signal of TC19 and TC84 was similar to
what was observed for the lipopeptide daptomycin [12], but diﬀered
from pore-forming lantibiotic Nisin A, the K+/Na+ channel-forming
peptide mix Gramicidin ABCD [12] and the helical pore-forming pep-
tide KLA-1 [13]. A delay in DiSC3(5) signal was also observed for Nisin
A compared to valinomycin, but the delay was shorter than for TC19
and TC84 (Fig. 1). BP2 caused a similar DiSC3(5) signal proﬁle as Nisin
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A. Additional valinomycin was added after 30min of treatment with the
AMPs and a further increase in DiSC3(5) release was observed sug-
gesting that complete dissipation of the membrane potential does not
occur after treatment with TC19, TC84 and BP2. A further increase in
DiSC3(5) release was not observed for valinomycin. Valinomycin
functions as a potassium ion carrier that speciﬁcally dissipates the
membrane potential in the presence of potassium ions [25], thus in-
creasing the concentration of valinomycin in the medium will not cause
further loss in membrane potential. In conclusion, these data led us to
infer that TC19 and TC84 might cause changes to the ﬂuidity to the
membrane similar to what has been seen for daptomycin [12].
3.2. TC19, TC84 and BP2 distort the membrane by creating ﬂuid
membrane domains
To evaluate whether our AMPs aﬀect membrane ﬂuidity the ﬂuor-
escent probe Laurdan was employed. Laurdan localizes at the hydro-
phobic-hydrophilic interface of the phospholipid bilayer where the
lauric acid tail of this ﬂuorescent probe is anchored in the phospholipid
acyl chain region [27]. In the gel phase (liquid ordered) phospholipids
are tightly packed and less water molecules are present than in the
loosely packed liquid-phase (liquid disordered) [27–29]. Upon excita-
tion, the dipolar moment of Laurdan is inﬂuenced by the dipolar mo-
ment of surrounding water molecules causing a spectral shift. Thus,
Laurdan anchored in a gel-phase (blue) will emit at a diﬀerent wave-
length compared to when the compound is present in a liquid mem-
brane-phase (red). We found that culturing B. subtilis in CMM (deﬁned
minimal medium) resulted in a smaller cell size compared to B. subtilis
cells obtained from rich LB medium cultures. Furthermore, previous
studies made use of B. subtilis cultured in LB to evaluate changes in
membrane ﬂuidity using Laurdan [12,13]. Hence to cover both minimal
and rich environmental conditions, we decided to study B. subtilis cells
obtained from both CMM and LB cultures when evaluating membrane
alterations.
TC19, TC84 and BP2 caused a rapid increase in Laurdan general
polarization (GP) values, suggesting an instant membrane rigidiﬁcation
(< 2min) after the addition of the peptides (Fig. 2A). The negative
controls treated with the solvent used for the peptides showed no
change in membrane ﬂuidity, whereas benzyl alcohol (BA) rapidly
ﬂuidized the membrane as expected. BA increases the penetration of
water molecules into the hydrophobic region of the phospholipid bi-
layer thus increasing the liquid-phase of the membrane [19,30]. Simi-
larly, daptomycin and the non-pore-forming cyclic hexapeptide cWFW
showed to cause rapid membrane rigidiﬁcation, and it was suggested
that the changes in ﬂuidity are due to direct insertion of these agents
into the membrane [12,13].
Laurdan ﬂuorescence microscopy images were evaluated for B.
subtilis cells cultured in CMM (Fig. 2B). However, B. subtilis cells cul-
tured in CMM was too small to visualize the eﬀect of the peptides on the
membrane, therefore changes in membrane ﬂuidity were evaluated
using LB cultured cells (Fig. 3A). The images conﬁrmed the increase in
ﬂuidity of BA treated cells compared to untreated cells (Fig. 3A and B).
After treatment with TC19, TC84 and BP2 the images revealed large
liquid-phase domains in the membrane, but an increase in gel-phase of
the membrane bulk (Fig. 3A and B). Staining with DiIC12, conﬁrmed the
formation of ﬂuid domains in the membrane after treatment with the
AMPs (Fig. 4). DiIC12 diﬀers from Laurdan in that it preferentially
partitions out of the gel-phase into the liquid-phase [20,31]. DiIC12 was
also employed to observe whether changes in the membrane ﬂuidity
will arise when treating the pathogenic Staphylococcus aureus (Fig. 4).
We also included the membrane permealizing lantibiotic Nisin A [26]
and alpha-helical peptide LL-37 [32]. We found, similar to B. subtilis,
the presence of ﬂuid domains in the membrane after treatment with
TC19, TC84 and BP2, but also with LL-37 and Nisin A.
To conﬁrm the observed alteration to the membrane and cytosol
leakage, B. subtilis PrpsD-sfGFP stained with the membrane dye, Nile
Red, were evaluated using SIM after treatment with lethal concentra-
tions of TC19, TC84 or BP2. Nile Red has a stronger signal when the
membrane is in ﬂuid phase. Untreated cells showed equal distribution
of Nile Red ﬂuorescence over the membrane. After treatment, B. subtilis
PrpsD-sfGFP showed perturbed membrane domains characterized by
unequal staining near the septum, but also at random areas in the
membrane similar to what was observed with the Laurdan GP images
(Fig. 5). These observations suggest that plasmolysis occurs when lethal
concentrations are used. The perturbed membrane areas were curved
inwards and the Nile Red signal appeared more intense at these per-
turbed membrane areas compared to the rest of the membrane, sug-
gesting that these areas were more ﬂuid than the rest (Fig. 5). Less
PrpsD-sfGFP signal was also observed at the perturbed membrane areas.
3.3. Conﬁrmation of membrane alterations using an Alexa Fluor 488
labelled TC84
To observe the possible binding site of the AMPs, TC84 was em-
ployed as a reference peptide and labelled with Alexa Fluor 488.
Labelling of TC84 with Alexa Fluor 488 altered the activity of the
peptide as the MIC value was higher than the highest tested con-
centration of 56 μM (Fig. S1). At 56 μM Alexa Fluor 488 labelled TC84
(Alexa488-TC84) we did observe an extended lag time of the cell
growth in the culture in comparison with the growth kinetics observed
in cultures exposed to lower Alexa488-TC84 concentrations. Fifty-six
micromolar Alexa488-TC84 reduced the culture by one log CFU/ml
Fig. 1. Graphs depicting the loss of membrane potential after treatment with TC19, TC84, BP2, Nisin A and valinomycin using the ﬂuorescent dye DiSC3(5). After the
addition of DiSC3(5), the dye accumulates within the cell deploying its membrane potential. a) Valinomycin, TC19, TC84, BP2 and Nisin A was added 10min after the
addition of DiSC3(5). Valinomycin rapidly dissipates the membrane potential (ΔΨ) in the presence of potassium ions. TC19, TC84, BP2 and the control Nisin A
dissipated the membrane potential, but slower than valinomycin. b) Additional valinomycin was added 25min after the addition of the peptides to completely
dissipate the membrane potential. Results are expressed at relative ﬂuorescence in arbitrary units (a.u).
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after 15min of treatment, possibly causing the lag time in the growth
curve observed. We hypothesize that the anionic bulky Alexa Fluor 488
moiety reduces the electrostatic interaction required for cationic TC84
to interact with the anionic cell envelope of B. subtilis. A reduction in
antimicrobial activity of magainin 2, PGLa [34] and daptomycin [12]
was also observed after ﬂuorophore labelling. Nevertheless, in the case
of the labelled magainin 2 and PGL the desired synergism was observed
as with the unlabelled peptides. Also, exposure of cells to ﬂuorescently
labelled daptomycin lead to a similar phenotype as was observed after
incubation of B. subtilis cells with the unlabelled peptide. In summary,
results obtained with labelled peptides, including our Alexa488-TC84,
should be interpreted with caution. The data should only be used as a
proxy for the understanding of the mechanistic details of the mode of
action of the parent peptides. Alexa488-TC84 at 14 μM bound rapidly
(≤5min) to the membrane. The ﬂuorescent compound accumulated at
the septum, but also at lower intensity at random areas of the mem-
brane (Fig. 6B). Anionic phospholipid CL were previously reported to
be located at the septum and poles of B. subtilis membranes [35], sug-
gesting that the peptides interact with this anionic phospholipid.
However, the location of CL are currently in dispute [36]. Moreover,
the Alexa488-TC84 binding sites co-localized with the ﬂuid domains
observed in the co-staining Laurdan GP images. The binding of
Alexa488-TC84 to the cell membrane was irreversible as the peptide
remained bound after multiple washing steps. These ﬁnding suggested
that TC84 might also bind to and remain within the phospholipid bi-
layer of the cell membrane. Laurdan stained cells were treated with
14 μM Alexa488-TC84 for 5min to evaluate whether ﬂuid domains are
formed. Indeed, Alexa488-TC84 was bound to ﬂuidic areas (Fig. 6B).
These ﬁnding suggest that the ﬂuid domains observed are formed at
sites of accumulation of the peptides in the membrane. We hypothesize
that the insertion of the peptides into the membrane locally increases
the concentration of water molecules and the mobility of the acyl
chains. The presence of the rigid bulk membrane, however, is unclear.
The ﬂuorescent probe DiIC12 has been shown to preferentially partition
into ﬂuid domains, as reported by Baumgart et al. [20]. We pre-stained
our cells with DiIC12 before treatment with the peptides and found
DiIC12 to accumulate in regions that are most likely in liquid-phase
(liquid disordered) (Fig. 4.). There is a possibility that the phospholi-
pids (unsaturated or branched) associated with liquid disordered re-
gions are removed from the bulk membrane and accumulate in the
observed ﬂuid domains. However, this is a speculation, and we know of
no method to determine the characteristics of phospholipids locally in
the membrane.
Similar to situation with unlabelled TC84, the change in ﬂuidity
induced by the insertion of Alexa488-TC84 into the membrane caused
the peripheral membrane protein MreB (MreB-mCherry) and the in-
tegral membrane protein PBP2b (PBP2b-mCherry) to delocalize
(Fig. 6C). Cells treated with the low concentration of 14 μM Alexa488-
TC84 had membrane invaginations where the peptide was bound
(Fig. 6D). At a high concentration of 56 μM Alexa488-TC84, an in-
vaginated membrane with co-localizing peptide was also observed and
the peptide accumulated intracellularly. Combining Alexa488-TC84
with unlabelled TC84, which has a much higher antimicrobial activity,
also showed that the Alexa488-TC84 accumulate intracellularly
(Fig. 6E), suggesting that the membrane perturbation caused by the
AMPs might facilitate the entering of the peptides into the cells.
3.4. Membrane alterations in B. subtilis phospholipid synthesis mutants are
insuﬃcient to prevent the AMPs' activity
The membrane has been shown to be the primary target of TC19,
TC84 and BP2. Therefore, we questioned whether the activity of the
peptides is dependent on the composition of the phospholipid bilayer of
the B. subtilis cell membrane. The general consensus is that cationic
antimicrobial peptides are attracted to the bacterial cell surface through
electrostatic interaction. This is considered to be due to the cationic
nature of the peptide and the anionic surface charge of the cell envelope
[37]. This hypothesis is supported by the notion that modiﬁcations of
the anionic PG reducing the net negative surface charge of the bacteria,
also reduce the eﬃcacy of antimicrobial peptides. For example, lysy-
lation of PG resulted in reduction in susceptibility of Staphylococcus
aureus to antimicrobial peptides [38–44]. Lysyl-PG was also shown to
Fig. 2. Laurdan staining of B. subtilis after peptide treatment to determine membrane ﬂuidity alterations. (A) Spectroscopy measurements showed the rapid rigi-
diﬁcation of the membrane after the addition of TC19, TC84 and BP2 with an increase in Laurdan GP values compared to the untreated cells. Benzyl alcohol, a known
membrane ﬂuidizer, indeed increased membrane ﬂuidity with a Laurdan GP value lowered compared to that of untreated cells. Laurdan GP values were normalized
against those of untreated cells. Fluorescence microscopy images showed that TC19, TC84 and BP2, after 5min of treatment, create ﬂuid domains in the membrane of
B. subtilis cultured in CMM. Scale bar represent 2 μm.
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be important for B. subtilis peptide resistance when a loss of function of
MprF caused an increase in sensitivity to Nisin [45]. The activity of
daptomycin were also aﬀected by the presence of PG and lysyl-PG in the
membrane [46–49].
The phospholipids that contribute to the negative charge of the
membrane are PG, cardiolipins (CL) and lysyl-PG. PgsA, phosphati-
dylglycerophosphate synthase, catalyzes PG formation [45]. Cardio-
lopin synthases YwnE, YwjE and YwiE condense two PG molecules to
form CL [35,45]. MprF, lysyl-phosphatidylglycerol synthase, transfers a
lysyl group to PG forming lysyl-PG thus reducing the negative charge of
the phospholipid [45]. To assess the role of these phospholipids in
TC19, TC84 and BP2 susceptibility, four mutants with altered
phospholipid composition were used. B. subtilis strain MHB001, referred
to as 1A700-PgsA, has the essential gene pgsA replaced by the IPTG
inducible Pspac-pgsA [50]. B. subtilis strain HB5337 (referred to as
CU1065-MprF) has the non-essential gene mprF deleted [45]. B. subtilis
strain HB5362 (referred to as CU1065-YwnE) has the ywnE (clsA) gene
deleted, which encodes the major cardiolipin synthase [45]. B. subtilis
strain SDB206 (referred to as 168-CL) had all three cardiolipin syn-
thases ywnE, ywjE and ywiE deleted, and should have hardly any CL
[35].
Lipidomic analyses were performed of the B. subtilis strains to con-
ﬁrm the expected changes to the phospholipid composition of the
mutants. The membrane of the CU1065-MprF strain had lysyl-PG
Fig. 3. Laurdan staining of B. subtilis after peptide treatment to determine membrane ﬂuidity alterations. (A) Fluorescence microscopy images showed that TC19,
TC84 and BP2, after 5 min of treatment, create ﬂuid domains in the membrane of B. subtilis cultured in LB. The rest of the membrane was more rigid. (D)
Quantiﬁcation of pixel intensity showed that the ﬂuid domains were more ﬂuid and the rigid areas were more rigid than in the untreated cells. Scale bar represent
2 μm.
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decreased, PE increased, and PG and CL at similar levels compared to
the wild type CU1065 (Fig. 7). The results conﬁrm that the content of
the positively charged phospholipid lysyl-PG in the membrane is re-
duced. The CU1065-MprF strain, however, was not more sensitive to
TC19, TC84 and BP2 as compared to the wild type CU1065 (Fig. 7),
implying that lowering lysyl-PG in the membrane does not have an
eﬀect on the susceptibility for these AMPs.
The CU1065-YwnE strain had CL and PE reduced in the membrane
compared to the wild type CU1065 (Fig. S1). Similar to the CU1065-
YwnE strain, the 168-CL strain had CL and PE reduced without a clear
Fig. 4. Fluorescence microscopy images of DiIC12 stained B. subtilis and S. aureus to conﬁrm changes in membrane ﬂuidity after treatment with TC19, TC84 and BP2.
After 5min of treatment of B. subtilis cells, ﬂuid membrane domains were observed similar to those observed in Laurdan stained cells (Fig. 2 and 3). Fluid lipid
domains are clearly visible after treatment with all three peptides in B. subtilis cells cultured in LB and CMM. After 5min of treatment of S. aureus cells, ﬂuid lipid
domains were also clearly visible in the membrane. The membrane active alpha-helical peptide LL-37 also caused the formation of ﬂuid domains in the membrane S.
aureus. Lantibiotic Nisin A also showed changes in the ﬂuidity of the membrane after treatment.
Fig. 5. Structured illumination microscopy (SIM) imaging of B. subtilis PrpsD-sfGFP after peptide treatment. B. subtilis PrpsD-sfGFP cultured in LB and CMM after
treatment with lethal concentrations of TC19 (14 μM), TC84 (14 μM) and BP2 (3.5 μM) to probe for membrane deformation and possible cytosolic leakage. The
membrane was stained with Nile red. LB and CMM cultured cells showed deformed membrane areas at the cell poles and septum, but also at random locations on the
membrane (turquois arrows). Leakage of the cytosol was observed with the loss of PrpsD-sfGFP signal, but membrane deformation did not always cause cytosol
leakage. Scale bar represents 2 μm.
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change in lysyl-PG content in the membrane (Fig. S1). The PG (32:0),
PG (32:0) [M+OH]−, PG (33:1), PG (34:0), PG (34:0) [M+OH]−
and PG (35:0) content, however, appeared to have increased suggesting
that the reduction in CL might be compensated for by increasing the PG
content. Furthermore, PG will not be converted to CL due to the lack of
cardiolipin synthases. The reduced CL and PE content of the membrane
did not decrease the eﬃcacy of the AMPs (Fig. 7), suggesting that CL
and PE are not essential for the membrane activity of the AMPs. The
presence of PG and possibly the increase of the diﬀerent PG species,
might be suﬃcient for the AMPs to interact with the membrane.
Strain 1A700-PgsA cultured in the presence of 1mM IPTG had an
increase in PE, PG (31:1) and PG (32:1) without a clear change in lysyl
PG or CL compared to the wild type 1A700 (Fig. S2). The net eﬀect on
the overall membrane charge might be negligible. Changes to the
1A700-PgsA strain cultured in the presence of 0.1mM IPTG were more
complex. The strain had an increase in cytidine diphosphate
diacylglycerol (CDPDG), and a reduction in CL and PG. However, PG
(31:1), PG (32:1), PG (34:0), PG (34:1) and PG (35:0) were increased in
the membrane. An increase of about 40% PE and 30% lysyl-PG, of the
total PE and lysyl-PG, were also observed. The combined eﬀect of these
changes on the net charge of the membrane is diﬃcult to predict. Strain
1A700-PgsA cultured in 1mM IPTG or 0.1mM IPTG was not more nor
less sensitive compared to the wild type 1A700 to the activity of the
AMPs (Fig. 7). In conclusion, these results show that changes in lipid
composition due to particular mutations are not necessarily entirely
predictable and suggest that changes in phospholipid composition of
the membrane mentioned above are not essential in determining the
AMPs eﬃcacy.
4. Discussion
In this study, we aimed to determine the membrane perturbation
Fig. 6. Assessment of possible binding sites of TC84 using Alexa Fluor 488. (A) Laurdan stained cell were treated with Alexa488-TC84 to observed changes in
membrane ﬂuidity. The accumulation of Alexa488-TC84 overlapped with the location of the ﬂuid domains (red arrows). (B) Treatment of B. subtilis mutants with the
peripheral membrane protein MreB (MreB-mCherry) and integral membrane protein PBP2b (PBP2b-mCherry) fused to the mCherry red ﬂuorescent protein. MreB-
mCherry and PBP2b-mCherry were delocalized after treatment. Delocalized PBP2b-mCherry did not co-localize with Alexa488-TC84 (turquoise arrows). (C) SIM
images of Nile Red stained B. subtilis treated with Alexa488-TC84. (D) Alexa488-TC84 combined with TC84 in a 1:1 ratio (ﬁnal concentration of 14 μM). All
treatments were for 5min and cells were washed with phosphate buﬀered saline (PBS) after treatment. Scale bar represent 2 μm.
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mechanism of amphipathic cationic AMPs derived from thrombocidin,
TC19 and TC84, and designer peptide BP2. TC19 and TC84 dissipated
the membrane potential gradually, whereas BP2 dissipated the mem-
brane potential faster than TC19 and TC84. The DiSC3(5) proﬁles of
TC19 and TC84 were similar to what was observed for lipopeptide
daptomycin [12] but diﬀerent from the instant membrane dissipation
proﬁle of the K+/Na+ channel-forming peptide mix Gramicidin ABCD
[12], the helical pore-forming peptide KLA-1 [13] and Nisin in our
study. Daptomycin was shown to signiﬁcantly perturb the membrane
without permeabilising it, by inserting into regions of increased ﬂuidity
(RIFs) [12]. We hypothesized that our amphipathic cationic AMPs,
TC19, TC84 and BP2, would alter membrane ﬂuidity similar to dapto-
mycin. Unlike daptomycin, TC19, TC84 and BP2 caused rapid mem-
brane permeabilisation without causing overt cell lysis, as observed
with the TEM and Sytox Green staining images (Omardien, submitted).
Daptomycin has shown with DiIC12 staining to cause domains in B.
subtilis membranes after only 10min of treatment, which were enlarged
after 60min of treatment [12]. These thin domains appeared rigid with
Laurdan staining due to the combination of daptomycin and lipids
(dapto-lipids) that reduced the mobility of the phospholipids [12].
TC19, TC84 and BP2, however, caused formation of large, clearly de-
ﬁned ﬂuid domains (with Laurdan and DiIC12), while the rest of the
membrane appeared rigid after 5min of treatment. The observation
that similar ﬂuid domains co-localized with Alexa488-labelled TC84,
suggest that it is the interaction of TC19, TC84 and BP2 with the
phospholipid bilayer that creates these ﬂuid domains. Fluid domains
were also observed in the DiIC12 stained membrane of S. aureus when
treated with TC19, TC84, BP2, the lantibiotic Nisin A and alpha-helical
peptide LL-37. Phase boundary defects caused by the phase separation
of lipids (Epand et al., 2006, 2008; Epand and Epand, 2009; Jean-
François et al., 2008) or membrane thinning [3] have been proposed as
a means of compromising the membrane barrier by peptides. We have
showed that TC19, TC84 and BP2 causes essential membrane bound
proteins to delocalize (Omardien, submitted). Alexa488-labelled TC84
also showed to cause delocalization of peripheral membrane protein
MreB (MreB-mCherry) and integral membrane protein PBP2b (PBP2b-
mCherry). Peripheral membrane protein MreB has shown to delocalize
due to a loss of membrane potential [33], but the integral membrane
protein PBP2b has not shown to be sensitive to changes in the mem-
brane potential. We assume that the changes in packing of the phos-
pholipids in the bilayer also contributes to the delocalization of these
essential proteins.
The Nile Red staining of peptide-treated cells showed that the
peptides cause membrane invagination which indicates plasmolysis.
The ﬂuid domains and membrane invaginations co-localized. Staining
with Alexa-TC84 conﬁrmed that membrane invagination occurs where
the peptide accumulates. The irregular localization of ATP synthase
subunit AtpA fused to the green ﬂuorescent protein (GFP) upon
Fig. 7. The survival of B. subtilis wild type and membrane phospholipid mutant strains after peptide treatment. The susceptibility of wild type strains B. subtilis 1A700
was compared with that of a B. subtilis pgsA conditional mutant (strain 1A700-PgsA) cultured at 1mM and 0.1mM IPTG (the minimal IPTG level compatible with
strain viability). The survival of a B. subtilis mprF deletion mutant (strain CU1065-MprF) lacking lysyl-phosphatidylglycerol (lysyl-PG) and a B. subtilis ywnE deletion
mutant (strain CU1065-YwnE) lacking cardiolopin (CL) was compared with survival of wild type B. subtilis CU1065. Wild type strain 168 was compared with triple
cardiolipin synthase deletion mutant (strain 168-CL). No signiﬁcant diﬀerences in susceptibility to TC19, TC84 and BP2 were observed between the mutant strains
and their wild type. Treatment with TC19, TC84 and BP2 was for 30min. Standard error bars represent four biological repeats.
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treatment with TC19, TC84 and BP2 (Omardien, submitted) also con-
ﬁrms membrane invagination. The irregular distribution of AtpA has
been used previously as an indicator for abnormal membrane curva-
tures [19]. Interestingly, in contrast to our peptides, daptomycin had no
eﬀect on the localization of AtpA suggesting that no abnormal mem-
brane curvatures occurs [12] and even though cyclic hexapeptide cWFC
altered the localization of AtpA it appeared diﬀerent from TC19, TC84
and BP2 treated cells (Omardien, submitted). AtpA-GFP was absent
from the rigid domains caused by cWFC [13], whereas TC19, TC84 and
BP2 causes “patchy” localization of AtpA-GFP. Alexa488-TC84 when
used at a high concentration and when combined with TC84 was found
intracellularly after treatment, suggesting that TC84 and probably TC19
and BP2 accumulate intracellularly after the membrane barriers is
compromised. This suggests that the targeting of intracellular anionic
macromolecular components might also be part of the mechanism of
killing the cells.
To determine whether the membrane deformations caused by the
peptides are dependent on the composition of the membrane, we ex-
amined the eﬀects of TC19, TC84 and BP on various B. subtilis mutants
with altered membrane compositions. The cyclic hexapeptide cWFW in
vitro caused de-mixing of PG/PE bilayers [51,52], but in vivo showed
not to be dependent on the PE and CL content of the membrane to
create rigid membrane domains [13]. It was proposed that cWFW
creates a phase separation by changing the physical state of the mem-
brane and not by inducing the cellular enrichment for a speciﬁc phos-
pholipid [13]. Likewise, in our study we did not observe changes in
eﬃcacy of TC19, TC84 and BP2 against B. subtilis mutants with altered
membrane compositions, including mutants with reduced membrane
PE and CL content. The B. subtilis mutant SDB206 (168-CL) used in the
study for cWFW was expected to have no CL present in the cell mem-
brane [13], but in our lipidomic analysis B. subtilis mutant SDB206
showed to have PG in the membrane even though the PE and CL con-
tent was reduced. We concluded that in absence of CL the essential
anionic PG might compensate for this phospholipid, enabling the in-
teraction of the peptides with the membrane that leads to phase
boundary defects [4,7]. The cationic phospholipid lysyl-PG has been
implicated in the resistance of Gram-positives against cationic anti-
microbial peptides as it is thought to reduce the net negative surface
charge of the membrane, reducing the electrostatic interaction with the
cationic peptides. We did however not observe a reduced sensitivity to
TC19, TC84 and BP2 for the B. subtilis mutants with reduced lysyl-PG
(strain CU1065-MprF) content, suggesting that altering the overall
surface charge of the phospholipid bilayer of the cells might not be
suﬃcient to prevent the activity of these AMPs. However, we did not
address the eﬀects of modifying the cell wall, such as D-alanylation of
the teichoic acids, or thickening of the cell wall. These cell wall and cell
membrane modiﬁcation have previously shown to contribute to re-
sisting AMPs by Gram-positives such as Staphylococcus aureus, En-
terococcus faecalis and Clostridium diﬃcile; reviewed in Omardien et al.,
2016 [53].
4.1. Model of the interaction of TC19, TC84 and BP2 with the membrane
We hypothesize that the cationic residues (arginine, histidine and
lysine) of TC19, TC84 and BP2 interact with the anionic phospholipids
of the bacterial membrane bilayer. The anionic phospholipids are CL
and PG [54], but the membrane sites of these phospholipids are unclear
and in dispute [36]. Interaction of the cationic peptide with the anionic
Fig. 8. Model of the eﬀects of TC19, TC84 and BP2 on membrane of B. subtilis. (1) The AMPs align on the surface of the membrane. The cationic AMPs have a higher
aﬃnity for the anionic phospholipids and therefore accumulate at areas on the membrane associated with these anionic phospholipids such as phosphatidylglycerol
and cardiolipin. (2) In in vitro studies with artiﬁcial membranes, both the insertion and the alignment of the AMPs in parallel to the membrane have been suggested to
cause “free volume” in the bilayer [3]. The “free volume” is compensated for which leads to membrane thinning and an increase in ﬂuidity of the hydrophobic core.
This phenomenon can contribute to an increase of the liquid disordered area (ﬂuid domains) of the membrane. Changes in the membrane homeostasis cause the
delocalization of essential membrane bound proteins. Eventually, leakage of the cytosol and entering of the AMPs into the cell occurs.
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head-groups of the phospholipids will coalesce the phospholipids, thus
increasing the free space in the bilayer. The AMPs might be aligning in
parallel to the membrane or insert into the upper layer of the phos-
pholipid bilayer, but the nature of the peptide's interaction with the
membrane is still unclear (Fig. 8). However, the contact of the AMPs
with the phospholipid bilayer causes ﬂuid domains to occur, but we
hypothesize that the initial change in membrane ﬂuidity does not cause
cell death. In studies with phospholipid vesicles leakage due to a
packing defect in the bilayer has been shown in case of a shift in the
environmental temperature [55], where this does not lead to cell death.
Peripheral membrane proteins are displaced from the membrane, while
integral membrane proteins likely remain membrane bound but are
misplaced relative to their normal location. We think that a phase
boundary defect eventually occurs between the ﬂuid (liquid disordered)
and gel (liquid ordered) membrane areas compromising the membrane
barrier and increasing the permeability of the membrane. The inability
of the bacterial cell to prevent the unfavourable changes to the mem-
brane eventually manifest as membrane inward curvature putatively
causing perturbation of the normal membrane physiology and hence
favouring the observed gradual dissipation of the membrane potential,
internalization of the peptides and leakage of the cytosol.
In conclusion, we show in vivo that the cationic peptides, TC19,
TC84 and BP2, compromise the membrane barrier by altering the dis-
tribution of ﬂuid and rigid areas of the membrane by creating ﬂuid
domains (“pores”).
Competing ﬁnancial interest statement
The authors have no competing interests to declare.
Transparency document
The Transparency document associated with this article can be
found in the online version.
Acknowledgements
The authors acknowledge Edward A. de Koning and Terrens N.V.
Saaki for constructing the strains EKB154 and TNVS205, and Kate
Feller for contributing to Fig. 6 during her Bachelor's internship. S.
Omardien acknowledges the Erasmus Mundus Action 2 program
(EMA2) and University of Amsterdam for funding. S.A.J. Zaat is sup-
ported by the FP7-HEALTH-2011 grant 278890, BALI – Bioﬁlm Alli-
ance. The authors declare that they have no conﬂict of interest.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbamem.2018.06.004.
References
[1] K.A. Brogden, Antimicrobial peptides: pore formers or metabolic inhibitors in
bacteria? Nat. Rev. Microbiol. 3 (2005) 238–250, http://dx.doi.org/10.1038/
nrmicro1098.
[2] L.T. Nguyen, E.F. Haney, H.J. Vogel, The expanding scope of antimicrobial peptide
structures and their modes of action, Trends Biotechnol. 29 (2011) 464–472, http://
dx.doi.org/10.1016/j.tibtech.2011.05.001.
[3] K. Lohner, New strategies for novel antibiotics: peptides targeting bacterial cell
membranes, Gen. Physiol. Biophys. 28 (2009) 105–116, http://dx.doi.org/10.
4149/gpb_2009_02_105.
[4] R.M. Epand, R.F. Epand, Lipid domains in bacterial membranes and the action of
antimicrobial agents, Biochim. Biophys. Acta Biomembr. 1788 (2009) 289–294,
http://dx.doi.org/10.1016/j.bbamem.2008.08.023.
[5] F. Jean-François, S. Castano, B. Desbat, B. Odaert, M. Roux, M.H. Metz-Boutigue,
E.J. Dufourc, Aggregation of cateslytin β-sheets on negatively charged lipids pro-
motes rigid membrane domains. A new mode of action for antimicrobial peptides?
Biochemistry 47 (2008) 6394–6402, http://dx.doi.org/10.1021/bi800448h.
[6] R.F. Epand, M.A. Schmitt, S.H. Gellman, R.M. Epand, Role of membrane lipids in
the mechanism of bacterial species selective toxicity by two α/β-antimicrobial
peptides, Biochim. Biophys. Acta Biomembr. 1758 (2006) 1343–1350, http://dx.
doi.org/10.1016/j.bbamem.2006.01.018.
[7] R.F. Epand, B.P. Mowery, S.E. Lee, S.S. Stahl, R.I. Lehrer, S.H. Gellman, R.M. Epand,
Dual mechanism of bacterial lethality for a cationic sequence-random copolymer
that mimics host-defense antimicrobial peptides, J. Mol. Biol. 379 (2008) 38–50,
http://dx.doi.org/10.1016/j.jmb.2008.03.047.
[8] L. Thøgersen, B. Schiøtt, T. Vosegaard, N.C. Nielsen, E. Tajkhorshid, Peptide ag-
gregation and pore formation in a lipid bilayer: a combined coarse-grained and all
atom molecular dynamics study, Biophys. J. 95 (2008) 4337–4347, http://dx.doi.
org/10.1529/biophysj.108.133330.
[9] D. Sengupta, H. Leontiadou, A.E. Mark, S.J. Marrink, Toroidal pores formed by
antimicrobial peptides show signiﬁcant disorder, Biochim. Biophys. Acta
Biomembr. 1778 (2008) 2308–2317, http://dx.doi.org/10.1016/j.bbamem.2008.
06.007.
[10] H. Leontiadou, A.E. Mark, S.J. Marrink, Antimicrobial peptides in action, J. Am.
Chem. Soc. 128 (2006) 12156–12161, http://dx.doi.org/10.1021/ja062927q.
[11] D.L. Parton, E.V. Akhmatskaya, M.S.P. Sansom, Multiscale simulations of the an-
timicrobial peptide maculatin 1.1: water permeation through disordered ag-
gregates, J. Phys. Chem. B 116 (2012) 8485–8493, http://dx.doi.org/10.1021/
jp212358y.
[12] A. Müller, M. Wenzel, H. Strahl, F. Grein, T. Saaki, B. Kohl, T. Siersma, J. Bandow,
H. Sahl, T. Schneider, L. Hamoen, Daptomycin inhibits bacterial cell envelope
synthesis by interfering with ﬂuid membrane microdomains, Proc. Natl. Acad. Sci.
U. S. A. 113 (2016) E7077–E7086, http://dx.doi.org/10.1073/pnas.1611173113.
[13] K. Scheinpﬂug, M. Wenzel, O. Krylova, J.E. Bandow, M. Dathe, H. Strahl,
Antimicrobial peptide cWFW kills by combining lipid phase separation with auto-
lysis, Sci. Rep. 7 (2017) 44332, , http://dx.doi.org/10.1038/srep44332.
[14] P.H.S. Kwakman, A.a. Te Velde, C.M.J.E. Vandenbroucke-Grauls, S.J.H. van
Deventer, S.A.J. Zaat, Treatment and prevention of Staphylococcus epidermidis
experimental biomaterial-associated infection by bactericidal peptide 2,
Antimicrob. Agents Chemother. 50 (2006) 3977–3983, http://dx.doi.org/10.1128/
AAC.00575-06.
[15] C. Anagnostopoulos, J. Spizizen, Requirements for transformation in Bacillus subtilis,
J. Bacteriol. 81 (1961) 741–746.
[16] S. Halbedel, M. Kawai, R. Breitling, L.W. Hamoen, SecA is required for membrane
targeting of the cell division protein DivIVA in vivo, Front. Microbiol. 5 (2014) 58, ,
http://dx.doi.org/10.3389/fmicb.2014.00058.
[17] P. Breeuwer, T. Abee, Assessment of the membrane potential, intracellular pH and
respiration of bacteria employing ﬂuorescence techniques, Mol. Microbiol. Ecol.
Man, Second Ed, Kluwer Academic Publishers, Netherlands, 2004, pp. 3465–3481, ,
http://dx.doi.org/10.1007/978-1-4020-2177-0_801.
[18] H.S. Hiemstra, G. Duinkerken, W.E. Benckhuijsen, R. Amons, R.R.P. de Vries,
B.O. Roep, J.W. Drijfhout, The identiﬁcation of CD4+ T cell epitopes with dedi-
cated synthetic peptide libraries, Proc. Natl. Acad. Sci. 94 (1997) 10313–10318,
http://dx.doi.org/10.1073/pnas.94.19.10313.
[19] H. Strahl, F. Bürmann, L.W. Hamoen, The actin homologue MreB organizes the
bacterial cell membrane, Nat. Commun. 5 (2014) 3442, , http://dx.doi.org/10.
1038/ncomms4442.
[20] T. Baumgart, G. Hunt, E.R. Farkas, W.W. Webb, G.W. Feigenson, Fluorescence
probe partitioning between Lo/Ld phases in lipid membranes, Biochim. Biophys.
Acta Biomembr. 1768 (2007) 2182–2194, http://dx.doi.org/10.1016/j.bbamem.
2007.05.012.
[21] W. Zhang, F.K. Yang, Y. Han, R. Gaikwad, Z. Leonenko, B. Zhao, Surface and tri-
bological behaviors of the bioinspired polydopamine thin ﬁlms under dry and wet
conditions, Biomacromolecules 14 (2013) 394–405, http://dx.doi.org/10.1021/
bm3015768.
[22] H. Strahl, S. Ronneau, B.S. González, D. Klutsch, C. Schaﬀner-Barbero,
L.W. Hamoen, Transmembrane protein sorting driven by membrane curvature, Nat.
Commun. 6 (2015) 8728, , http://dx.doi.org/10.1038/ncomms9728.
[23] J. Krijgsveld, S.A.J. Zaat, J. Meeldijk, P.A. van Veelen, G. Fang, B. Poolman,
E. Brandt, J.E. Ehlert, A.J. Kuijpers, G.H.M. Engbers, J. Feijen, J. Dankert,
Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal
deletion products of CXC chemokines, J. Biol. Chem. 275 (2000) 20374–20381,
http://dx.doi.org/10.1074/jbc.275.27.20374.
[24] M. Síp, P. Herman, J. Plásek, V. Hrouda, Transmembrane potential measurement
with carbocyanine dye diS-C3-(5): fast ﬂuorescence decay studies, J. Photochem.
Photobiol. B 4 (1990) 321–328, http://dx.doi.org/10.1016/1011-1344(90)
85037-W.
[25] H.M. Shapiro, Cell membrane potential analysis, Methods Mol. Biol, 1994, pp.
121–133, , http://dx.doi.org/10.1016/S0091-679X(08)61713-6.
[26] I. Wiedemann, R. Benz, H.G. Sahl, Lipid II-mediated pore formation by the peptide
antibiotic nisin: a black lipid membrane study, J. Bacteriol. 186 (2004) 3259–3261,
http://dx.doi.org/10.1128/JB.186.10.3259-3261.2004.
[27] T. Parasassi, G. de Stasio, G. Ravagnan, R.M. Rusch, E. Gratton, Quantitation of
lipid phases in phospholipid vesicles by the generalized polarization of Laurdan
ﬂuorescence, Biophys. J. 60 (1991) 179–189, http://dx.doi.org/10.1016/S0006-
3495(91)82041-0.
[28] T. Parasassi, E. Gratton, Membrane lipid domains and dynamics as detected by
Laurdan ﬂuorescence, J. Fluoresc. 5 (1995) 59–69, http://dx.doi.org/10.1007/
BF00718783.
[29] T. Parasassi, G. de Stasio, A. D'Ubaldo, E. Gratton, Phase ﬂuctuation in phospholipid
membranes revealed by Laurdan ﬂuorescence, Biophys. J. 57 (1990) 1179–1186,
http://dx.doi.org/10.1016/S0006-3495(90)82637-0.
[30] I. Konopásek, K. Strzalka, J. Svobodová, Cold shock in Bacillus subtilis: diﬀerent
eﬀects of benzyl alcohol and ethanol on the membrane organisation and cell
adaptation, Biochim. Biophys. Acta Biomembr. 1464 (2000) 18–26, http://dx.doi.
S. Omardien et al. BBA - Biomembranes 1860 (2018) 2404–2415
2414
org/10.1016/S0005-2736(99)00240-0.
[31] J. Zhao, J. Wu, S.L. Veatch, Adhesion stabilizes robust lipid heterogeneity in su-
percritical membranes at physiological temperature, Biophys. J. 104 (2013)
825–834, http://dx.doi.org/10.1016/j.bpj.2012.12.047.
[32] K.A.H. Wildman, D.-K. Lee, A. Ramamoorthy, Mechanism of lipid bilayer disruption
by the human antimicrobial peptide, LL-37, Biochemistry 42 (2003) 6545–6558,
http://dx.doi.org/10.1021/bi0273563.
[33] H. Strahl, L.W. Hamoen, Membrane potential is important for bacterial cell division,
Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 12281–12286, http://dx.doi.org/10.
1073/pnas.1005485107.
[34] A. Marquette, E.S. Salnikov, E. Glattard, C. Aisenbrey, B. Bechinger, Magainin 2-
PGLa interactions in membranes - two peptides that exhibit synergistic enhance-
ment of antimicrobial activity, Curr. Top. Med. Chem. 16 (2015) 65–75 http://
www.ncbi.nlm.nih.gov/pubmed/26139118.
[35] F. Kawai, M. Shoda, R. Harashima, Y. Sadaie, H. Hara, K. Matsumoto, Cardiolipin
domains in Bacillus subtilis marburg membranes, J. Bacteriol. 186 (2004)
1475–1483, http://dx.doi.org/10.1128/JB.186.5.1475.
[36] A.-R. Pogmore, K.H. Seistrup, H. Strahl, The Gram-positive model organism Bacillus
subtilis does not form detectable cardiolipin-speciﬁc lipid domains, bioRxiv 44
(2017), http://dx.doi.org/10.1101/190306.
[37] N. Malanovic, K. Lohner, Antimicrobial Peptides Targeting Gram-positive Bacteria,
(2016), http://dx.doi.org/10.3390/ph9030059.
[38] Y.Q. Xiong, K. Mukhopadhyay, M.R. Yeaman, J. Adler-Moore, A.S. Bayer, T. David,
L. Angeles, Functional interrelationships between cell membrane and cell wall in
antimicrobial peptide-mediated killing of Staphylococcus aureus, Antimicrob. Agents
Chemother. 49 (2005) 3114–3121, http://dx.doi.org/10.1128/AAC.49.8.
3114–3121.2005.
[39] C. Weidenmaier, A. Peschel, V.A.J. Kempf, N. Lucindo, M.R. Yeaman, A.S. Bayer,
DltABCD- and MprF-mediated cell envelope modiﬁcations of Staphylococcus aureus
confer resistance to platelet microbicidal proteins and contribute to virulence in a
rabbit endocarditis model, Microbiology 73 (2005) 8033–8038, http://dx.doi.org/
10.1128/IAI.73.12.8033–8038.2005.
[40] H. Nishi, H. Komatsuzawa, T. Fujiwara, N. McCallum, M. Sugai, Reduced content of
lysyl-phosphatidylglycerol in the cytoplasmic membrane aﬀects susceptibility to
moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in
Staphylococcus aureus, Antimicrob. Agents Chemother. 48 (2004) 4800–4807,
http://dx.doi.org/10.1128/AAC.48.12.4800-4807.2004.
[41] U.L. Rajbhandary, D. Söll, Aminoacyl-tRNAs, the bacterial cell envelope, and an-
tibiotics, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 5285–5286, http://dx.doi.org/
10.1073/pnas.0801193105.
[42] A. Peschel, R.W. Jack, M. Otto, L.V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher,
W.F. Nieuwenhuizen, G. Jung, A. Tarkowski, K.P. van Kessel, J.A. van Strijp,
Staphylococcus aureus resistance to human defensins and evasion of neutrophil
killing via the novel virulence factor MprF is based on modiﬁcation of membrane
lipids with l-lysine, J. Exp. Med. 193 (2001) 1067–1076, http://dx.doi.org/10.
1084/jem.193.9.1067.
[43] S.J. Yang, C.C. Nast, N.N. Mishra, M.R. Yeaman, P.D. Fey, A.S. Bayer, Cell wall
thickening is not a universal accompaniment of the daptomycin nonsusceptibility
phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms,
Antimicrob. Agents Chemother. 54 (2010) 3079–3085, http://dx.doi.org/10.1128/
AAC.00122-10.
[44] A.S. Bayer, N.N. Mishra, G. Sakoulas, P. Nonejuie, C.C. Nast, J. Pogliano, K.T. Chen,
S.N. Ellison, M.R. Yeaman, S.J. Yanga, Heterogeneity of mprF sequences in me-
thicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance
between daptomycin and host defense antimicrobial peptides, Antimicrob. Agents
Chemother. 58 (2014) 7462–7467, http://dx.doi.org/10.1128/AAC.03422-14.
[45] L.I. Salzberg, J.D. Helmann, Phenotypic and transcriptomic characterization of
Bacillus subtilis mutants with grossly altered membrane composition, J. Bacteriol.
190 (2008) 7797–7807, http://dx.doi.org/10.1128/JB.00720-08.
[46] T.O. Khatib, H. Stevenson, M.R. Yeaman, A.S. Bayer, A. Pokorny, Binding of dap-
tomycin to anionic lipid vesicles is reduced in the presence of lysyl-phosphati-
dylglycerol, Antimicrob. Agents Chemother. 60 (2016) 5051–5053, http://dx.doi.
org/10.1128/AAC.00744-16.
[47] S.J. Yang, N.N. Mishra, A. Rubio, A.S. Bayer, Causal role of single nucleotide
polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin re-
sistance, Antimicrob. Agents Chemother. 57 (2013) 5658–5664, http://dx.doi.org/
10.1128/AAC.01184-13.
[48] T.T. Tran, J.M. Munita, C.A. Arias, Mechanisms of drug resistance: daptomycin
resistance, Ann. N. Y. Acad. Sci. 1354 (2015) 32–53, http://dx.doi.org/10.1111/
nyas.12948.
[49] A.Y. Peleg, S. Miyakis, D.V. Ward, A.M. Earl, A. Rubio, D.R. Cameron, S. Pillai,
R.C. Moellering, G.M. Eliopoulos, Whole genome characterization of the mechan-
isms of daptomycin resistance in clinical and laboratory derived isolates of
Staphylococcus aureus, PLoS One 7 (2012), http://dx.doi.org/10.1371/journal.pone.
0028316.
[50] M. Hashimoto, H. Takahashi, Y. Hara, H. Hara, K. Asai, Y. Sadaie, K. Matsumoto,
Induction of extracytoplasmic function sigma factors in Bacillus subtilis cells with
membranes of reduced phosphatidylglycerol content, Genes Genet. Syst. 84 (2009)
191–198, http://dx.doi.org/10.1266/ggs.84.191.
[51] A. Arouri, M. Dathe, A. Blume, Peptide induced demixing in PG/PE lipid mixtures: a
mechanism for the speciﬁcity of antimicrobial peptides towards bacterial mem-
branes? Biochim. Biophys. Acta Biomembr. 1788 (2009) 650–659, http://dx.doi.
org/10.1016/j.bbamem.2008.11.022.
[52] S. Finger, A. Kerth, M. Dathe, A. Blume, The eﬃcacy of trivalent cyclic hexapeptides
to induce lipid clustering in PG/PE membranes correlates with their antimicrobial
activity, Biochim. Biophys. Acta Biomembr. 1848 ( (2015) 2998–3006, http://dx.
doi.org/10.1016/j.bbamem.2015.09.012.
[53] S. Omardien, S. Brul, S.A.J. Zaat, Antimicrobial activity of cationic antimicrobial
peptides against Gram-positives: current progress made in understanding the mode
of action and the response of bacteria, Front. Cell Dev. Biol. 4 (2016) 1–16, http://
dx.doi.org/10.3389/fcell.2016.00111.
[54] I. Barák, K. Muchová, The role of lipid domains in bacterial cell processes, Int. J.
Mol. Sci. 14 (2013) 4050–4065, http://dx.doi.org/10.3390/ijms14024050.
[55] L.M. Hays, J.H. Crowe, W. Wolkers, S. Rudenko, Factors aﬀecting leakage of
trapped solutes from phospholipid vesicles during thermotropic phase transitions,
Cryobiology 42 (2001) 88–102, http://dx.doi.org/10.1006/cryo.2001.2307.
S. Omardien et al. BBA - Biomembranes 1860 (2018) 2404–2415
2415
